Sarepta Therapeutics falls sharply after suspending shipments of Elevidys for infusions in non-ambulatory patients because of ...

President Donald Trump would have unique influence over the operations of U.S. Steel under the terms of the investment being ...

TOKYO (Reuters) -Nippon Steel shares rose on Monday after U.S. President Donald Trump approved its $14.9 billion bid for U.S.

The Pittsburgh-based steel maker and Nippon Steel plan $11 billion in new investments by 2028 after indicating that they plan ...

Administration officials secured a deal that will give the president unusual influence over a private company, and could ...

China churned out a lot less steel in May compared to the previous year as mills responded to the government’s pledge to cut ...

The Japanese company secured its much-wanted prize late last week when President Trump approved the $14.1 billion purchase of ...

The Japanese company has already committed to heavy investment in U.S. Steel and a U.S.-controlled board of directors at the ...

Sarepta Therapeutics shares plunged 36% after the company reported a second case of acute liver failure resulting in death from taking Elevidys, which is a gene therapy for patients with Duchenne ...

BEIJING: China’s crude steel output slipped sharply in May compared to the prior year, surprising analysts and keeping ...